ESME PHARMA LIMITED

Company Registration Number:
10346210 (England and Wales)

Unaudited micro entity accounts for the year ended 31 August 2024

Period of accounts

Start date: 01 September 2023

End date: 31 August 2024

ESME PHARMA LIMITED

Contents of the Financial Statements

for the Period Ended 31 August 2024

Company Information - 3
Report of the Directors - 4
Profit and Loss Account - 5
Balance sheet - 6
Footnotes to the Balance Sheet - 8

ESME PHARMA LIMITED

Company Information

for the Period Ended 31 August 2024




Director: Emem Ekaette
Registered office: 124
City Road
London
England
EC1V 2NX
Company Registration Number: 10346210 (England and Wales)

ESME PHARMA LIMITED

Directors' Report Period Ended 31 August 2024

The directors present their report with the financial statements of the company for the period ended 31 August 2024

Directors

The directors shown below have held office during the whole of the period from 01 September 2023 to 31 August 2024
Emem Ekaette

This report was approved by the board of directors on 20 September 2024
And Signed On Behalf Of The Board By:

Name: Emem Ekaette
Status: Director

ESME PHARMA LIMITED

Profit and Loss Account

for the Period Ended 31 August 2024


2024
£

2023
£
Other Income 10,700 8,240
Other charges ( 7,575 ) ( 9,002 )
Profit or (Loss) for Period 3,125 ( 762 )

ESME PHARMA LIMITED

Balance sheet

As at 31 August 2024


2024
£

2023
£
Fixed Assets: 2,264 2,264
Current assets: 6,618 5,492
Creditors: amounts falling due within one year: ( 21,580 ) ( 23,580 )
Net current assets (liabilities): ( 14,962 ) ( 18,088 )
Total assets less current liabilities: ( 12,698 ) ( 15,824 )
Total net assets (liabilities): ( 12,698 ) ( 15,824 )
Capital and reserves: ( 12,698 ) ( 15,824 )

ESME PHARMA LIMITED

Balance sheet continued

For the year ending 31 August 2024 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions of the small companies regime applicable to micro-entities.

This report was approved by the board of directors on 20 September 2024
And Signed On Behalf Of The Board By:

Name: Emem Ekaette
Status: Director

The notes form part of these financial statements

ESME PHARMA LIMITED

Footnotes to the Financial Statements

for the Period Ended 31 August 2024

  • 1. Employee Information

    Average number of employees: 0

ESME PHARMA LIMITED

Footnotes to the Financial Statements

for the Period Ended 31 August 2024

  • 2. Off balance sheet disclosure

    No